Apolipoprotein A-1 is a negative target of v-Jun overexpression

M Hadman1, W Lin, L Bush

  • 1Department of Microbiology and Immunology, Eastern Virginia Medical School, Norfolk 23501, USA.

Oncogene
|March 3, 1998
PubMed

Insights

The v-Jun oncogene downregulates apolipoprotein A-1 expression by affecting promoter activity, potentially impacting cholesterol metabolism. This regulation differs from c-Jun

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The Jun oncogene regulates cell proliferation and differentiation by binding to gene regulatory regions.
  • Understanding oncogene-induced gene expression changes is crucial for cancer research.

Purpose of the Study:

  • To identify genes downregulated by v-Jun overexpression.
  • To investigate the mechanism of v-Jun-mediated gene regulation.
  • To explore the relationship between v-Jun, apolipoprotein A-1, and cholesterol metabolism.

Main Methods:

  • Gene isolation and characterization via homology searches.
  • RNA half-life analysis.
  • Reporter gene assays using promoter fragments.
  • Oncogene overexpression in chicken embryo fibroblasts (CEF).

Main Results:

  • A gene downregulated by v-Jun, but not c-Jun, was identified as chicken apolipoprotein A-1 (ApoA-1).
  • v-Jun downregulates ApoA-1 at the promoter activity level, not via RNA stability.
  • Myc and v-Src oncogenes also downregulated ApoA-1 expression in CEF.

Conclusions:

  • v-Jun directly represses apolipoprotein A-1 gene transcription.
  • Altered apolipoprotein A-1 levels due to v-Jun may affect cholesterol metabolism.
  • v-Jun oncogene exhibits distinct regulatory effects compared to c-Jun.

Related Concept Videos

RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...